China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
China Pharma Holdings, Inc. (CPHI) Reports Q3 Loss of $0.04
November 15, 2018 6:03 AM ESTChina Pharma Holdings, Inc. (NYSE: CPHI) reported Q3 EPS of ($0.04), versus ($0.05) reported last year. Revenue for the quarter came in at $2.3 million, versus $3.16 million reported last year.
In a statement from Ms. Zhilin Li, China Pharma\'s Chairman and CEO, "It is the Company's top... More
